Method for treatment of inflammation and pain in mammals
View Patent ↗A composition for treating inflammation and pain in mammals, particularly humans. Effective amounts of a boswellic acid, a curcuminoid, a gingerol, a capsaicinoid, a bioflavonoid, and a vitamin C source, in various combinations, all preferably from a botanical source, are blended to form a dose for oral administration. Administration of the dose provides relief from pain and inflammation of connective tissue. The dose may be administered as a tablet, a liquid, or a powder.
1. A method of treating an ailment involving pain and inflammation in a mammal comprising administering to the mammal a composition comprising, in parts by weight, about 10 to 1800 parts of Boswellia gum extract comprising at least 10% by weight of boswellic acids, and about 50 to 400 parts of turmeric gum extract comprising at least about 30% by weight of curcuminoids.
2. The method of claim 1 , wherein the composition further comprises gingerol.
3. The method of claim 1 , wherein the composition further comprises bioflavonoids.
4. The method of claim 3 , wherein the bioflavonoids are selected from the group consisting of quercetin, isoquercetin, hesperidin, rutin, troxirutin, naringen, naringenin, limonene, chrysin, isoflavones, proanthocyanidins, anthocyanidins, ellagic acid, catechin, and tannin.
5. The method of claim 3 , wherein the bioflavonoids comprise citrus bioflavonoids.
6. The method of claim 1 , wherein the composition further comprises cayenne pepper.
7. The method of claim 1 , wherein the composition further comprises vitamin C.
8. The method of claim 1 , wherein the composition further comprises a mineral selected from the group consisting of calcium and phosphorus.
9. The method of claim 1 , wherein the ailment afflicts connective tissue.
10. The method of claim 1 , wherein the ailment is selected from the group consisting of rheumatoid arthritis, osteoarthritis, juvenile rheumatoid arthritis, gout, low back pain, minor soft tissue injury, minor burn, sprain, headache, general muscle soreness, swelling, stiffness, and chronic inflammatory disease.
11. The method of claim 1 , wherein the composition further comprises a non-steroidal anti-inflammatory drug.